SCHEMBL2084331

SCHEMBL2084331

CC(C)(C)c1cc(N)n(-c2cc(CN(C(=O)O)C(C)(C)C)c3ccccc3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.40
MAPK13 O15264 9/20 0.40
MAPK12 P53778 9/20 0.40
MAPK11 Q15759 9/20 0.40
GRN P28799 1/20 0.40
SORT1 Q99523 1/20 0.40
DDR2 Q16832 3/20 0.39
MAPK9 P45984 3/20 0.39
SRC P12931 1/20 0.39
JAK2 O60674 1/20 0.37
CDK8 P49336 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PAK4 O96013 1/20 0.36
RET P07949 1/20 0.36
PDGFRA P16234 1/20 0.36
AURKB Q96GD4 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
MAP4K5 Q9Y4K4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2025620 0.83 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL2082236 0.83 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL5052142 0.82 MAPK14 (0.45) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL2081248 0.81 CYP1A2 (0.40) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL2082586 0.80 RAB9A (0.42) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL5052166 0.79 GRN (0.43) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL2025289 0.79 HPGD (0.43) MAPK14MAPK13MAPK12MAPK11GRN
Hydrochloric Acid SCHEMBL2025286 0.78 HPGD (0.42) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL4486598 0.77 RIPK2 (0.39) MAPK14MAPK13MAPK12MAPK11GRN
SCHEMBL2083183 0.77 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163756-B2 For example,1-(3-t-butyl-1- (1,2,3,4-tetrahydro- isoquinolin-6-yl)-1H- pyrazol-5-yl)-3-(3- cyanophenyl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies DECIPHERA PHARMACEUTICALS, LLC (US) 2012-04-24 US disclosed